Actively Recruiting
Effect of Virtual Reality-based Therapy on Negative Symptoms in People with Schizophrenia
Led by Hospital de la Florida Dra. Eloiza Diaz · Updated on 2024-09-19
102
Participants Needed
1
Research Sites
174 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A randomised, controlled, double-blind clinical trial will be carried out to evaluate the effectiveness of a VR assisted treatment for negative symptoms in people with schizophrenia. Patients with a standardised diagnosis of schizophrenia meeting the inclusion criteria will receive 12 weekly sessions of VR assisted therapy plus treatment as usual (TAU). A control group will be exposed to a neutral VR environment plus TAU. The hypothesis is that patients who are treated with active VR assisted therapy will have less negative symptoms as rated by the PANSS-N scale, compared to the control group. The protocol was approved by the hospital ethics committee of the Servicio de Salud Metropolitano Suroriente. Patients sign an informed consent form, from which they may withdraw at any point during the intervention.
CONDITIONS
Official Title
Effect of Virtual Reality-based Therapy on Negative Symptoms in People with Schizophrenia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of schizophrenia confirmed by a psychiatrist using CIE-10 criteria
- Age between 18 and 65 years old
- Receiving outpatient care
- Clinically stable with no psychiatric hospitalizations in the last 6 months and not currently awaiting hospitalization
- No active substance abuse disorder except nicotine
- Able to provide informed consent
You will not qualify if you...
- Previous diagnosis of learning disability according to ICD-10 or clinical history
- Difficulties with verbal expression due to language or medical reasons
- Deafness or blindness
- Physical disabilities preventing use of VR devices
- Predominant positive symptoms (PANNS-C > 0)
- Catatonic symptoms
- Previous diagnosis of epilepsy
- Neurodegenerative disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Clínico La Florida
Santiago, Santiago Metropolitan, Chile
Actively Recruiting
Research Team
J
Javiera Libuy, MD
CONTACT
J
Jonathan Alarcón, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here